Barbara Kornek
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Vaccination of immunocompromised individuals: Expert opinion - update 2026
Journal: Wiener klinische Wochenschrift
Published: April 14, 2026
Integration of retinal layer thinning into NEDA-3 predicts disability progression in multiple sclerosis.
Journal: Journal of neurology
Published: March 09, 2026
The impact of OSCAR-IB quality control and manual segmentation on retinal atrophy rates in multiple sclerosis.
Journal: Frontiers in neurology
Published: February 25, 2026
OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 07, 2026
Corrigendum to "High association of MOG-IgG antibodies in children with bilateral optic neuritis" [Eur. J. Paediatr. Neurol. 27 (2020) 86-93].
Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
Published: October 10, 2025
Association of treatment decision with personality, coping strategies and impulsivity in patients with multiple sclerosis.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: October 01, 2025
Association Between Retinal Layer Atrophy With Clinical and Radiologic Progression in People With Relapsing Multiple Sclerosis.
Journal: Neurology
Published: September 29, 2025
Complications of Therapeutic Plasma Exchange in Pediatric Neuroimmune Disorders.
Journal: Children (Basel, Switzerland)
Published: September 10, 2025
Serum neurofilament light chain and glial fibrillary acidic protein levels are associated with inner retinal layer thinning in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 20, 2025
Reduced brain volumes in children with radiologically isolated syndrome.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 30, 2025
Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR).
Journal: Journal of neurology
Published: July 04, 2025
Last Updated: 09/26/2026